Company intelligence / Profile preview

Ladder

Widnes, England, United Kingdomjoinladder.com ↗

Ownership: Private
Development stage: Commercial

Overview

Ladder Therapeutics is developing an in-silico drug discovery platform that leverages machine learning, novel chemistry approaches, and RNA biology to identify new therapeutic opportunities within the dark genome. The company is currently focused on research and experimental development with no disclosed clinical results or late-stage assets.

Therapeutic areas: Other
Modalities: Small moleculeRNA therapy
Industry: Biotech

Beyond the preview

Go deeper on Ladder.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ladder.

Explore the full profile